Clinical Trial Update: Psilocybin Cancer Anxiety Study [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial evaluating psilocybin for cancer-related anxiety has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-10-03